Joan Rosenbaum Asarnow1, Jennifer L Hughes2, Kalina N Babeva3, Catherine A Sugar3. 1. University of California Los Angeles, David Geffen School of Medicine. Electronic address: JAsarnow@mednet.ucla.edu. 2. Center for Depression Research and Clinical Care (CDRCC), University of Texas Southwestern Medical School, Dallas. 3. University of California Los Angeles, David Geffen School of Medicine.
Abstract
OBJECTIVE: Suicide is a leading cause of death. New data indicate alarming increases in suicide death rates, yet no treatments with replicated efficacy or effectiveness exist for youths with self-harm presentations, a high-risk group for both fatal and nonfatal suicide attempts. We addressed this gap by evaluating Safe Alternatives for Teens and Youths (SAFETY), a cognitive-behavioral, dialectical behavior therapy-informed family treatment designed to promote safety. METHOD: Randomized controlled trial for adolescents (12-18 years of age) with recent (past 3 months) suicide attempts or other self-harm. Youth were randomized either to SAFETY or to treatment as usual enhanced by parent education and support accessing community treatment (E-TAU). Outcomes were evaluated at baseline, 3 months, or end of treatment period, and were followed up through 6 to 12 months. The primary outcome was youth-reported incident suicide attempts through the 3-month follow-up. RESULTS: Survival analyses indicated a significantly higher probability of survival without a suicide attempt by the 3-month follow-up point among SAFETY youths (cumulative estimated probability of survival without suicide attempt = 1.00, standard error = 0), compared to E-TAU youths (cumulative estimated probability of survival without suicide attempt = 0.67, standard error = 0.14; z = 2.45, p = .02, number needed to treat = 3) and for the overall survival curves (Wilcoxon χ21 = 5.81, p = .02). Sensitivity analyses using parent report when youth report was unavailable and conservative assumptions regarding missing data yielded similar results for 3-month outcomes. CONCLUSION: Results support the efficacy of SAFETY for preventing suicide attempts in adolescents presenting with recent self-harm. This is the second randomized trial to demonstrate that treatment including cognitive-behavioral and family components can provide some protection from suicide attempt risk in these high-risk youths. Clinical trial registration information-Effectiveness of a Family-Based Intervention for Adolescent Suicide Attempters (The SAFETY Study); http://clinicaltrials.gov/; NCT00692302.
RCT Entities:
OBJECTIVE: Suicide is a leading cause of death. New data indicate alarming increases in suicide death rates, yet no treatments with replicated efficacy or effectiveness exist for youths with self-harm presentations, a high-risk group for both fatal and nonfatal suicide attempts. We addressed this gap by evaluating Safe Alternatives for Teens and Youths (SAFETY), a cognitive-behavioral, dialectical behavior therapy-informed family treatment designed to promote safety. METHOD: Randomized controlled trial for adolescents (12-18 years of age) with recent (past 3 months) suicide attempts or other self-harm. Youth were randomized either to SAFETY or to treatment as usual enhanced by parent education and support accessing community treatment (E-TAU). Outcomes were evaluated at baseline, 3 months, or end of treatment period, and were followed up through 6 to 12 months. The primary outcome was youth-reported incident suicide attempts through the 3-month follow-up. RESULTS: Survival analyses indicated a significantly higher probability of survival without a suicide attempt by the 3-month follow-up point among SAFETY youths (cumulative estimated probability of survival without suicide attempt = 1.00, standard error = 0), compared to E-TAU youths (cumulative estimated probability of survival without suicide attempt = 0.67, standard error = 0.14; z = 2.45, p = .02, number needed to treat = 3) and for the overall survival curves (Wilcoxon χ21 = 5.81, p = .02). Sensitivity analyses using parent report when youth report was unavailable and conservative assumptions regarding missing data yielded similar results for 3-month outcomes. CONCLUSION: Results support the efficacy of SAFETY for preventing suicide attempts in adolescents presenting with recent self-harm. This is the second randomized trial to demonstrate that treatment including cognitive-behavioral and family components can provide some protection from suicide attempt risk in these high-risk youths. Clinical trial registration information-Effectiveness of a Family-Based Intervention for Adolescent Suicide Attempters (The SAFETY Study); http://clinicaltrials.gov/; NCT00692302.
Authors: Gregory K Brown; Thomas Ten Have; Gregg R Henriques; Sharon X Xie; Judd E Hollander; Aaron T Beck Journal: JAMA Date: 2005-08-03 Impact factor: 56.272
Authors: David A Brent; Dana L McMakin; Betsy D Kennard; Tina R Goldstein; Taryn L Mayes; Antoine B Douaihy Journal: J Am Acad Child Adolesc Psychiatry Date: 2013-09-29 Impact factor: 8.829
Authors: David A Brent; Laurence L Greenhill; Scott Compton; Graham Emslie; Karen Wells; John T Walkup; Benedetto Vitiello; Oscar Bukstein; Barbara Stanley; Kelly Posner; Betsy D Kennard; Mary F Cwik; Ann Wagner; Barbara Coffey; John S March; Mark Riddle; Tina Goldstein; John Curry; Shannon Barnett; Lisa Capasso; Jamie Zelazny; Jennifer Hughes; Sa Shen; S Sonia Gugga; J Blake Turner Journal: J Am Acad Child Adolesc Psychiatry Date: 2009-10 Impact factor: 8.829
Authors: Lars Mehlum; Anita J Tørmoen; Maria Ramberg; Egil Haga; Lien M Diep; Stine Laberg; Bo S Larsson; Barbara H Stanley; Alec L Miller; Anne M Sund; Berit Grøholt Journal: J Am Acad Child Adolesc Psychiatry Date: 2014-07-22 Impact factor: 8.829
Authors: Guy S Diamond; R Roger Kobak; E Stephanie Krauthamer Ewing; Suzanne A Levy; Joanna L Herres; Jody M Russon; Robert J Gallop Journal: J Am Acad Child Adolesc Psychiatry Date: 2018-10-30 Impact factor: 8.829
Authors: Mary J O'Connor; Larissa C Portnoff; Michael Lebsack-Coleman; Katrina M Dipple Journal: Birth Defects Res Date: 2019-01-24 Impact factor: 2.344
Authors: Joan Rosenbaum Asarnow; Martha C Tompson; Alexandra M Klomhaus; Kalina Babeva; David A Langer; Catherine A Sugar Journal: J Child Psychol Psychiatry Date: 2019-12-15 Impact factor: 8.982
Authors: William Gardner; Kathleen Pajer; Paula Cloutier; Roger Zemek; Lisa Currie; Simon Hatcher; Ian Colman; Dayna Bell; Clare Gray; Mario Cappelli; Daniel Rodriguez Duque; Isac Lima Journal: Can J Psychiatry Date: 2019-06-11 Impact factor: 4.356
Authors: Elizabeth McCauley; Michele S Berk; Joan R Asarnow; Molly Adrian; Judith Cohen; Kathyrn Korslund; Claudia Avina; Jennifer Hughes; Melanie Harned; Robert Gallop; Marsha M Linehan Journal: JAMA Psychiatry Date: 2018-08-01 Impact factor: 21.596
Authors: Kalina N Babeva; Alexandra M Klomhaus; Catherine A Sugar; Olivia Fitzpatrick; Joan R Asarnow Journal: Suicide Life Threat Behav Date: 2019-07-26